Dendritic Cell Immunotherapy Combined with Cytokine-Induced Killer Cells Effectively Suppresses Established Hepatocellular Carcinomas in Mice

References

• Andersen MH, Keikavoussi P, Brocker EB, et al. (2001). Induction of systemic CTL responses in melanoma patients by dendritic cell vaccination: Cessation of CTL responses is associated with disease progression. Int J Cancer, 94 (6), 820–4.
   PubMed Web of Science ®Google Scholar
• Asada H, Kishida T, Hirai H, et al. (2006). Combination vaccine of dendritic cells (DCs) and T cells effectively suppressed preestablished malignant melanoma in mice. Cancer Lett, 240 (1), 83–93. doi: 10.1016/j.canlet.2005.08.030.
   PubMed Web of Science ®Google Scholar
• Baker J, Verneris MR, Ito M, et al. (2001). Expansion of cytolytic CD8(+) natural killer T cells with limited capacity for graft-versus-host disease induction due to interferon gamma production. Blood, 97 (10), 2923–31.
   PubMed Web of Science ®Google Scholar
• Banchereau J, Steinman RM. (1998). Dendritic cells and the control of immunity. Nature, 392 (6673), 245–52. doi: 10.1038/32588.
   PubMed Web of Science ®Google Scholar
• Chang DH, Dhodapkar MV. (2003). Dendritic cells and immunotherapy for cancer. Int J Hematol, 77 (5), 439–43.
   PubMed Web of Science ®Google Scholar
• Duan XZ, Zhuang H, Wang M, et al. (2005). Decreased numbers and impaired function of circulating dendritic cell subsets in patients with chronic hepatitis B infection (R2). J Gastroenterol Hepatol, 20 (2), 234–42. doi: 10.1111/j.1440-1746.2004.03529.x.
   PubMed Web of Science ®Google Scholar
• El-Serag HB. (2011). Hepatocellular carcinoma. N Engl J Med, 365 (12), 1118–27. doi: 10.1056/NEJMra1001683.
   PubMed Web of Science ®Google Scholar
• El-Serag HB, Rudolph KL. (2007). Hepatocellular carcinoma: Epidemiology and molecular carcinogenesis. Gastroenterol, 132 (7), 2557–76. doi: 10.1053/j.gastro.2007.04.061.
   PubMed Web of Science ®Google Scholar
• Eshima K, Chiba S, Suzuki H, et al. (2012). Ectopic expression of a T-box transcription factor, eomesodermin, renders CD4(+) Th cells cytotoxic by activating both perforin- and FasL-pathways. Immunol Lett, 144 (1–2), 7–15. doi: 10.1016/j.imlet.2012.02.013.
   PubMed Web of Science ®Google Scholar
• Ikai I, Arii S, Okazaki M, et al. (2007). Report of the 17th nationwide follow-up survey of primary liver cancer in Japan. Hepatol Res, 37 (9), 676–91. doi: 10.1111/j.1872-034X.2007.00119.x.
   PubMed Web of Science ®Google Scholar
• Kakumu S, Ito S, Ishikawa T, et al. (2000). Decreased function of peripheral blood dendritic cells in patients with hepatocellular carcinoma with hepatitis B and C virus infection. J Gastroenterol Hepatol, 15 (4), 431–6.
   PubMed Web of Science ®Google Scholar
• Khazaie K, von Boehmer H. (2006). The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer. Semin Cancer Biol, 16 (2), 124–36. doi: 10.1016/j.semcancer.2005.11.006.
   PubMed Web of Science ®Google Scholar
• Kondo Y, Shimosegawa T. (2015). Significant roles of regulatory T cells and myeloid derived suppressor cells in hepatitis B virus persistent infection and hepatitis B virus-related HCCs. Int J Mol Sci, 16 (2), 3307–22. doi: 10.3390/ijms16023307.
   PubMed Web of Science ®Google Scholar
• Lim DS, Kim JH, Lee DS, et al. (2007). DC immunotherapy is highly effective for the inhibition of tumor metastasis or recurrence, although it is not efficient for the eradication of established solid tumors. Cancer Immunol Immunother, 56 (11), 1817–29. doi: 10.1007/s00262-007-0325-0.
   PubMed Web of Science ®Google Scholar
• Lu PH, Negrin RS. (1994). A novel population of expanded human CD3+CD56+ cells derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency. J Immunol, 153 (4), 1687–96.
   PubMed Web of Science ®Google Scholar
• Mellman I, Steinman RM. (2001). Dendritic cells: Specialized and regulated antigen processing machines. Cell 106 (3), 255–8.
   PubMed Web of Science ®Google Scholar
• Nestle FO, Alijagic S, Gilliet M, et al. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med, 4 (3), 328–32.
   PubMed Web of Science ®Google Scholar
• Nishikawa H, Arimoto A, Wakasa T, et al. (2013). Comparison of clinical characteristics and survival after surgery in patients with non-B and non-C hepatocellular carcinoma and hepatitis virus-related hepatocellular carcinoma. J Cancer, 4 (6), 502–13. doi: 10.7150/jca.6503.
   PubMed Web of Science ®Google Scholar
• O’Neill DW, Adams S, Bhardwaj N. (2004). Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood, 104 (8), 2235–46. doi: 10.1182/blood-2003-12-4392.
   PubMed Web of Science ®Google Scholar
• Schmidt J, Eisold S, Buchler MW, Marten A. (2004). Dendritic cells reduce number and function of CD4+CD25+ cells in cytokine-induced killer cells derived from patients with pancreatic carcinoma. Cancer Immunol Immunother 53 (11), 1018–26. doi: 10.1007/s00262-004-0554-4.
   PubMed Web of Science ®Google Scholar
• Schmidt-Wolf IG, Lefterova P, Mehta BA, et al. (1993). Phenotypic characterization and identification of effector cells involved in tumor cell recognition of cytokine-induced killer cells. Exp Hematol, 21 (13), 1673–9.
   PubMed Web of Science ®Google Scholar
• Schmidt-Wolf IG, Negrin RS, Kiem HP, et al. (1991). Use of a SCID mouse/human lymphoma model to evaluate cytokine-induced killer cells with potent antitumor cell activity. J Exp Med, 174 (1), 139–49.
   PubMed Web of Science ®Google Scholar
• Tada F, Abe M, Hirooka M, et al. (2012). Phase I/II study of immunotherapy using tumor antigen-pulsed dendritic cells in patients with hepatocellular carcinoma. Int J Oncol, 41 (5), 1601–9. doi: 10.3892/ijo.2012.1626.
   PubMed Web of Science ®Google Scholar
• Vivarelli M, Montalti R, Risaliti A. (2013). Multimodal treatment of hepatocellular carcinoma on cirrhosis: An update. World J Gastroenterol, 19 (42), 7316–26. doi: 10.3748/wjg.v19.i42.7316.
   PubMed Web of Science ®Google Scholar
• Yu JS, Liu G, Ying H, et al. (2004). Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma. Cancer Res, 64 (14), 4973–9. doi: 10.1158/0008-5472.CAN-03-3505.
   PubMed Web of Science ®Google Scholar
• Zamarron BF, Chen W. (2011). Dual roles of immune cells and their factors in cancer development and progression. Int J Biol Sci, 7 (5), 651–8.
   PubMed Web of Science ®Google Scholar
• Zhao HQ, Li WM, Lu ZQ, Yao YM. (2014). Roles of Tregs in development of hepatocellular carcinoma: A meta-analysis. World J Gastroenterol, 20 (24), 7971–8. doi: 10.3748/wjg.v20.i24.7971.
   PubMed Web of Science ®Google Scholar
• Zhong R, Teng J, Han B, Zhong H. (2011). Dendritic cells combining with cytokine-induced killer cells synergize chemotherapy in patients with late-stage non-small cell lung cancer. Cancer Immunol Immunother, 60 (10), 1497–502. doi: 10.1007/s00262-011-1060-0.
   PubMed Web of Science ®Google Scholar